Increasing concentrations of PLX4720 (1 h) inhibited pERK signalling in three BRAF-mutated melanoma cell lines (WM35, WM164 and 1205Lu), but not an NRAS-mutated cell line (WM1346) (Figure 1C). The gene discussed is BRAF; the disease is melanoma.